ALLMedicine™ Secondary Prevention of Coronary Artery Disease Center
Research & Reviews 65 results
https://clinicaltrials.gov/ct2/show/NCT02109523
Jan 11th, 2023 - Coronary artery bypass grafting (CABG) surgery is often performed in elderly patients, but non-adherence to post-CABG guideline medications is a common and serious clinical concern in this age group. A recent systematic review found that higher me...
https://clinicaltrials.gov/ct2/show/NCT05071495
Sep 7th, 2022 - Digital cardiology is gaining power in the field of preventive cardiology recently, and several trials have already shown good results of dietary therapy with digital cardiology. However, there has been no reports that showed effect of dietary cou...
https://doi.org/10.1016/j.clinthera.2022.06.009
Clinical Therapeutics; Yong J, Tian J et. al.
Jul 31st, 2022 - This review of colchicine, an effective anti-inflammatory agent, examines whether the reduction in ischemic events produced by colchicine translates to a reduction in mortality, the optimal duration of treatment, and the patient populations that b...
https://emedicine.medscape.com/article/164214-overview
Jul 22nd, 2022 - Overview Despite relatively recent declines in age-adjusted mortality, in 2013, cardiovascular disease (CVD) was the primary cause in nearly 801,000 deaths (30.8% of total deaths) in the United States. [1] In fact, CVD has been the leading cause o...
https://emedicine.medscape.com/article/164214-print
Jul 22nd, 2022 - Despite relatively recent declines in age-adjusted mortality, in 2013, cardiovascular disease (CVD) was the primary cause in nearly 801,000 deaths (30.8% of total deaths) in the United States.[1] In fact, CVD has been the leading cause of death in...
Guidelines 1 results
https://doi.org/10.1378/chest.08-0685
Chest Becker RC, Meade TW et. al.
Jul 24th, 2008 - The following chapter devoted to antithrombotic therapy for chronic coronary artery disease (CAD) is part of the Antithrombotic and Thrombolytic Therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition...
Clinicaltrials.gov 14 results
https://clinicaltrials.gov/ct2/show/NCT02109523
Jan 11th, 2023 - Coronary artery bypass grafting (CABG) surgery is often performed in elderly patients, but non-adherence to post-CABG guideline medications is a common and serious clinical concern in this age group. A recent systematic review found that higher me...
https://clinicaltrials.gov/ct2/show/NCT05071495
Sep 7th, 2022 - Digital cardiology is gaining power in the field of preventive cardiology recently, and several trials have already shown good results of dietary therapy with digital cardiology. However, there has been no reports that showed effect of dietary cou...
https://clinicaltrials.gov/ct2/show/NCT03198741
May 19th, 2022 - Dual antiplatelet therapy (DAPT) with aspirin and a platelet P2Y12 receptor inhibitor has become the cornerstone for secondary prevention of coronary artery disease. Long-term DAPT is recommended after percutaneous coronary intervention (PCI) in p...
https://clinicaltrials.gov/ct2/show/NCT03907293
Jan 13th, 2021 - An exercise-based cardiac rehabilitation (CR) programme is an established method of secondary prevention of coronary artery disease (CAD). Moreover, there is a body of evidence that supports the ability of this intervention to reduce hospital read...
https://clinicaltrials.gov/ct2/show/NCT03565978
Mar 5th, 2020 - The aim of the study is to evaluate the impacts of a cardiac post-discharge management solution in the population of cardiovascular (CVD) patients who were discharged from the hospital. The objectives include two parts: Objective 1: Assess the fea...
News 9 results
https://www.mdedge.com/ccjm/article/111934/cardiology/dual-antiplatelet-therapy-acute-coronary-syndromes-how-long-continue?channel=194
Meghana Halkar, MD, A. Michael Lincoff, MD
Sep 1st, 2016 - Percutaneous coronary intervention for acute coronary syndromes has evolved, and so, hand in hand, has antiplatelet therapy. With the advent of clopidogrel and newer agents, several studies demonstrated the benefits of dual antiplatelet therapy in.
https://www.mdedge.com/clinicianreviews/article/89585/cardiology/prescribing-statins-patients-acs-no-need-wait
Hanna Gov-Ari, MD, James J. Stevermer, MD, MSPH
Dec 22nd, 2014 - PRACTICE CHANGER Prescribe a high-dose statin before any patient with acute coronary syndrome (ACS) undergoes percutaneous coronary intervention (PCI); it may be reasonable to extend this to patients being evaluated for ACS. 1 STRENGTH OF RECOMMEND.
https://www.mdedge.com/familymedicine/article/89029/cardiology/prescribing-statins-patients-acs-no-need-wait
MDedge Family Medicine; Hanna Gov-Ari, MD, James J. Stevermer, MD, MSPH
Dec 1st, 2014 - PRACTICE CHANGER Prescribe a high-dose statin before any patient with acute coronary syndrome (ACS) undergoes percutaneous coronary intervention (PCI); it may be reasonable to extend this to patients being evaluated for ACS. 1 Strength of recommend.
https://www.mdedge.com/content/quality-guidelines-issued-ambulatory-cardiac-care-0
Alicia Ault
Jun 13th, 2011 - A group of professional societies on June 13 has issued the first set of quality improvement measures that focus on primary and secondary prevention of coronary artery disease and hypertension in the ambulatory setting. The 10 measures were charac.
https://www.mdedge.com/familymedicine/article/35713/cardiology/quality-guidelines-issued-ambulatory-cardiac-care
Family Practice News; Alicia Ault
Jun 13th, 2011 - A group of professional societies on June 13 has issued the first set of quality improvement measures that focus on primary and secondary prevention of coronary artery disease and hypertension in the ambulatory setting. The 10 measures were charac.
